November 15, 2018 / 12:07 IST
Reported Standalone quarterly numbers for Parabolic Drugs are:Net Sales at Rs 4.97 crore in September 2018 down 79.26% from Rs. 23.96 crore in September 2017.
Story continues below Advertisement
Quarterly Net Loss at Rs. 14.35 crore in September 2018 down 0.84% from Rs. 14.23 crore in September 2017.
EBITDA stands negative at Rs. 5.26 crore in September 2018 down 57.96% from Rs. 3.33 crore in September 2017.
Parabolic Drugs shares closed at 2.80 on November 14, 2018 (NSE) and has given -37.08% returns over the last 6 months and -68.18% over the last 12 months.
| Parabolic Drugs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'18 | Jun'18 | Sep'17 | | Net Sales/Income from operations | 4.92 | 12.85 | 23.96 | | Other Operating Income | 0.05 | -- | -- | | Total Income From Operations | 4.97 | 12.85 | 23.96 | | EXPENDITURE | | Consumption of Raw Materials | 4.56 | 10.31 | 21.53 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 3.47 | 1.20 | -0.88 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.72 | 1.13 | 2.46 | | Depreciation | 5.67 | 5.73 | 8.65 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.14 | 5.07 | 4.52 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -11.59 | -10.59 | -12.32 | | Other Income | 0.66 | 0.13 | 0.34 | | P/L Before Int., Excpt. Items & Tax | -10.93 | -10.46 | -11.98 | | Interest | 2.70 | 1.26 | 1.80 | | P/L Before Exceptional Items & Tax | -13.63 | -11.72 | -13.78 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -13.63 | -11.72 | -13.78 | | Tax | 0.72 | -1.20 | 0.45 | | P/L After Tax from Ordinary Activities | -14.35 | -10.52 | -14.23 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -14.35 | -10.52 | -14.23 | | Equity Share Capital | 61.89 | 61.89 | 61.89 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.32 | -1.70 | -2.30 | | Diluted EPS | -2.32 | -1.70 | -2.30 | | EPS After Extra Ordinary | | Basic EPS | -2.32 | -1.70 | -2.30 | | Diluted EPS | -2.32 | -1.70 | -2.30 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
